dafabet online bettingPress Releases Archives Media Inquiries In the News dafabet live dealer game FEATURED PRESS RELEASE June 12, 2024Cranbury Pharmaceuticals Receives U.S. FDA Approval for First Generic Version of Emflaza® Oral Suspension (deflazacort) for Duchenne Muscular Dystrophy May 29, 2024Tris Pharma Receives U.S. FDA Approval for Once-Daily ONYDA XR (clonidine hydrochloride) dafabet casino appExtended-Release Oral Suspension, the First-and-Only Liquid Non-Stimulant ADHD Medication April 16, 2024Tris Pharma Launches Digital Health Business to Develop and Commercialize Digital Products for ADHD February 7, 2024Tris Pharma Appoints Michael Magee as Vice President, Quality & Compliance January 22, 2024Tris Pharma Appoints Franchesca Fowler to Chief Compliance Officer dafabet live dealer gameand Vice President, General Counsel